Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4295)
All Articles published online
|
Feb 28, 2009 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deng LP, Gui XE, Zhang YX, Gao SC, Yang RR. Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2009; 15(8): 996-1003 [PMID: 19248201 DOI: 10.3748/wjg.15.996] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i8/996.htm |
| Number | Citing Articles |
| 1 |
Paula Tuma, Inmaculada Jarrin, Julia del Amo, Eugenia Vispo, Jose Medrano, Luz Martin-Carbonero, Pablo Labarga, Pablo Barreiro, Vincent Soriano. Survival of HIV-infected patients with compensated liver cirrhosis. AIDS 2010; 24(5): 745 doi: 10.1097/QAD.0b013e3283366602
|
| 2 |
Wendy A. Henderson, Angela C. Martino, Noriko Kitamura, Kevin H. Kim, Judith A. Erlen. Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease. AIDS Research and Treatment 2012; 2012: 1 doi: 10.1155/2012/169645
|
| 3 |
Tiziana Latronico, Claudia Mascia, Ilaria Pati, Paola Zuccala, Fabio Mengoni, Raffaella Marocco, Tiziana Tieghi, Valeria Belvisi, Miriam Lichtner, Vincenzo Vullo, Claudio Mastroianni, Grazia Liuzzi. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors. International Journal of Molecular Sciences 2016; 17(4): 455 doi: 10.3390/ijms17040455
|
| 4 |
Nicolas Di Benedetto, Mirta Peralta, Estela Alvarez, María Teresa Schroder, Claudio Estepo, Silvia Paz, Hugo Fainboim. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011. Annals of Hepatology 2014; 13(1): 38 doi: 10.1016/S1665-2681(19)30902-0
|
| 5 |
Dominique Salmon-Ceron, J. E. Arends, C. Leoni, C. Solas, G. Peytavin. Viral Hepatitis: Chronic Hepatitis C. 2019; : 141 doi: 10.1007/978-3-030-03757-4_7
|
| 6 |
Jonathan E. Schelfhout, Danijela A. Stojanovic, Amy Houtchens, Heidi M. Crane, Edward R. Cachay, Elizabeth R. Brown, Sonia M. Napravnik, Mari M. Kitahata, Michael S. Saag, Peter W. Hunt, Teresa L. Kauf, Joseph A. C. Delaney. Progression of Platelet Counts in Treatment Naïve HIV/HCV Co-Infection. World Journal of AIDS 2013; 3(01): 36 doi: 10.4236/wja.2013.31006
|
| 7 |
Laura E. Starbird, Hae‐Ra Han, Mark S. Sulkowski, Chakra Budhathoki, Nancy R. Reynolds, Jason E. Farley. Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary care. Research in Nursing & Health 2018; 41(5): 417 doi: 10.1002/nur.21903
|
| 8 |
Jing Qin Wu, Monica Miranda Saksena, Vincent Soriano, Eugenia Vispo, Nitin K Saksena. Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs. Virology Journal 2015; 12(1) doi: 10.1186/s12985-014-0236-6
|
| 9 |
Ramakrishna Behara, Nancy Reau. Updates on hepatitis C virus therapy in the direct-acting antiviral era. Current Opinion in Gastroenterology 2017; 33(3): 115 doi: 10.1097/MOG.0000000000000350
|
| 10 |
Florin Mihălţan, Ancuţa Constantin, Ruxandra Ulmeanu. Pulmonary TB Faces in the New Context of Drug Users. Internal Medicine 2023; 20(1): 57 doi: 10.2478/inmed-2023-0238
|
| 11 |
Chun-Yuan Lee, Pei-Hua Wu, Meng-Wei Lu, Tun-Chieh Chen, Po-Liang Lu, Kimberly Page. High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan. PLOS ONE 2021; 16(5): e0251158 doi: 10.1371/journal.pone.0251158
|
| 12 |
Macarena Garrido-Estepa, Pello Latasa, Javier Flores-Herrera, Luis García Comas. Hepatitis C and hepatitis C-related advanced liver disease hospitalisation trends before and after the Strategic Plan for Tackling Hepatitis C in the National Health System. European Journal of Gastroenterology & Hepatology 2021; 33(10): 1307 doi: 10.1097/MEG.0000000000001841
|
| 13 |
Helen Kovari, Rainer Weber. Influence of antiretroviral therapy on liver disease. Current Opinion in HIV and AIDS 2011; 6(4): 272 doi: 10.1097/COH.0b013e3283473405
|
| 14 |
Magnhild Gangsøy Kristiansen, Tore Jarl Gutteberg, Liisa Mortensen, Leif Kyrre Berg, Rasmus Goll, Jon Florholmen. Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway. Scandinavian Journal of Gastroenterology 2010; 45(6): 746 doi: 10.3109/00365521003690699
|
| 15 |
B. P. Linas, B. Wang, M. Smurzynski, E. Losina, R. J. Bosch, B. R. Schackman, J. Rong, P. E. Sax, R. P. Walensky, J. Schouten, K. A. Freedberg. The impact of HIV/HCV co‐infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. Journal of Viral Hepatitis 2011; 18(7): 506 doi: 10.1111/j.1365-2893.2010.01325.x
|
| 16 |
Ruoxi Wang, Nianqi Cui, Mengyun Long, Lihong Mu, Huan Zeng. Barriers to uptake of hepatitis C virus (HCV) health intervention among men who have sex with men in Southwest China: A qualitative study. Health & Social Care in the Community 2021; 29(2): 445 doi: 10.1111/hsc.13104
|
| 17 |
George N. Ioannou, Pamela Green, Elliott Lowy, Elijah J. Mun, Kristin Berry, Anand S. Mehta. Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis. PLOS ONE 2018; 13(9): e0204412 doi: 10.1371/journal.pone.0204412
|
| 18 |
Dominique Salmon‐Ceron, Pierre Nahon, Richard Layese, Valérie Bourcier, Philippe Sogni, Firouze Bani‐Sadr, Etienne Audureau, Laurence Merchadou, François Dabis, Linda Wittkop, Françoise Roudot‐Thoraval. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co‐infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End‐Stage Liver Disease as Compared to HCV Mono‐infected Patients. Hepatology 2019; 70(3): 939 doi: 10.1002/hep.30400
|
| 19 |
Eric P. F. Chow, Joseph D. Tucker, Frank Y. Wong, Eric J. Nehl, Yanjie Wang, Xun Zhuang, Lei Zhang, Julian W. Tang. Disparities and Risks of Sexually Transmissible Infections among Men Who Have Sex with Men in China: A Meta-Analysis and Data Synthesis. PLoS ONE 2014; 9(2): e89959 doi: 10.1371/journal.pone.0089959
|
| 20 |
Stefan K. Barta. HIV-associated Hematological Malignancies. 2016; : 227 doi: 10.1007/978-3-319-26857-6_20
|
| 21 |
Carlos Mínguez, Miguel García-Deltoro, Juan Flores, Maria-José Galindo, Marta Montero, Sergio Reus, Jorge Carmena, Mar Masiá, Concepción Amador, Enrique Ortega. Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients. AIDS 2018; 32(3): 337 doi: 10.1097/QAD.0000000000001699
|
| 22 |
Konstantin Shmagel, Evgeniya Saidakova. Advances in HIV and AIDS Control. 2018; doi: 10.5772/intechopen.76810
|
| 23 |
Francesco Negro. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy. Cold Spring Harbor Perspectives in Medicine 2020; 10(4): a036921 doi: 10.1101/cshperspect.a036921
|
| 24 |
Michael G. Ison, Madeleine Heldman. Hepatic Critical Care. 2018; : 191 doi: 10.1007/978-3-319-66432-3_15
|
| 25 |
Lisa R. C. Saud, Aline L. Chagas, Claudia Maccali, Paulo V. A. Pinto, Natally Horvat, Regiane S. S. M. Alencar, Claudia M. Tani, Edson Abdala, Flair J. Carrilho. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?. European Journal of Gastroenterology & Hepatology 2021; 33(4): 583 doi: 10.1097/MEG.0000000000002057
|
| 26 |
Frank Andersohn, Anne-Kathrin Claes, Werner Kulp, Jörg Mahlich, Jürgen Kurt Rockstroh. Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison. BMC Infectious Diseases 2015; 16(1) doi: 10.1186/s12879-015-1311-3
|
| 27 |
Caroline E Boeke, Clement Adesigbin, Chukwuemeka Agwuocha, Atiek Anartati, Hlaing Thazin Aung, Khin Sanda Aung, Gagandeep Singh Grover, Dang Ngo, Emi Okamoto, Alida Ngwije, Sabin Nsanzimana, Siddharth Sindhwani, Grace Singh, Ly Penh Sun, Nguyen Van Kinh, Wiendra Waworuntu, Craig McClure. Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries: the road to elimination. BMJ Global Health 2020; 5(12): e003767 doi: 10.1136/bmjgh-2020-003767
|
| 28 |
Louise Nygaard Clausen, Karen Astvad, Steen Ladelund, Mette Vang Larsen, Kristian Schønning, Thomas Benfield. Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individuals. AIDS 2012; 26(12): 1509 doi: 10.1097/QAD.0b013e3283553581
|
| 29 |
Ludmila Maistat, Natalija Kravchenko, Amulya Reddy. Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries. Hepatology, Medicine and Policy 2017; 2(1) doi: 10.1186/s41124-017-0026-z
|
| 30 |
K. V. Shmagel, V. A. Chereshnev. IMMUNE STATUS IN HIV-INFECTED PATIENTS COINFECTED WITH HEPАTITIS C VIRUS (HCV). HIV Infection and Immunosuppressive Disorders 2019; 10(4): 25 doi: 10.22328/2077-9828-2018-10-4-25-36
|
| 31 |
José A. Mira, Antonio Rivero-Juárez, Luis F. López-Cortés, José A. Girón-González, Francisco Téllez, Ignacio de los Santos-Gil, Juan Macías, Dolores Merino, Manuel Márquez, María J. Ríos-Villegas, Isabel Gea, Nicolás Merchante, Antonio Rivero, Almudena Torres-Cornejo, Juan A. Pineda. Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis. Clinical Infectious Diseases 2013; 56(11): 1646 doi: 10.1093/cid/cit103
|
| 32 |
Arka De, Swati Charak, Naveen Bhagat, Sahaj Rathi, Nipun Verma, Madhumita Premkumar, Sunil Taneja, Aman Sharma, Kapil Goel, Virendra Singh, Ajay Duseja. Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy. Journal of Viral Hepatitis 2023; 30(9): 740 doi: 10.1111/jvh.13844
|
| 33 |
L. B. Korolevskaya, E. V. Saydakova, K. V. Shmagel. BLOOD OF CYTOKINE LEVELS AND THEIR CORRELATIONS WITH LIVER INJURY IN PATIENTS COINFECTED WITH HIV AND HEPATITIS C VIRUS. HIV Infection and Immunosuppressive Disorders 2019; 11(3): 57 doi: 10.22328/2077-9828-2019-11-3-57-63
|
| 34 |
Tawhida Y Abdel-Ghaffar, Mostafa M Sira, Suzan El Naghi. Hepatitis C genotype 4: The past, present, and future. World Journal of Hepatology 2015; 7(28): 2792-2810 doi: 10.4254/wjh.v7.i28.2792
|
| 35 |
Siddharth A. Mahure, Joseph A. Bosco, James D. Slover, Jonathan Vigdorchik, Richard Iorio, Ran Schwarzkopf. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C. Clinical Orthopaedics & Related Research 2018; 476(2): 356 doi: 10.1007/s11999.0000000000000025
|
| 36 |
Linda Beatrice Mlunde, Bruno Fokas Sunguya, Jessie Kazeni Mbwambo, Omary Said Ubuguyu, Akira Shibanuma, Junko Yasuoka, Masamine Jimba, Dimitrios Paraskevis. A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania. PLOS ONE 2016; 11(2): e0148598 doi: 10.1371/journal.pone.0148598
|